193 related articles for article (PubMed ID: 24098375)
1. CIP2A influences survival in colon cancer and is critical for maintaining Myc expression.
Wiegering A; Pfann C; Uthe FW; Otto C; Rycak L; Mäder U; Gasser M; Waaga-Gasser AM; Eilers M; Germer CT
PLoS One; 2013; 8(10):e75292. PubMed ID: 24098375
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
3. Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.
Wang HW; Yang SH; Huang GD; Lin JK; Chen WS; Jiang JK; Lan YT; Lin CC; Hwang WL; Tzeng CH; Li AF; Yen CC; Teng HW
J Cancer Res Clin Oncol; 2014 Apr; 140(4):561-71. PubMed ID: 24493623
[TBL] [Abstract][Full Text] [Related]
4. CIP2A regulates MYC translation (via its 5'UTR) in colorectal cancer.
Denk S; Schmidt S; Schurr Y; Schwarz G; Schote F; Diefenbacher M; Armendariz C; Dejure F; Eilers M; Wiegering A
Int J Colorectal Dis; 2021 May; 36(5):911-918. PubMed ID: 33078202
[TBL] [Abstract][Full Text] [Related]
5. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A
J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954
[TBL] [Abstract][Full Text] [Related]
6. CIP2A inhibits PP2A in human malignancies.
Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.
Jung HM; Patel RS; Phillips BL; Wang H; Cohen DM; Reinhold WC; Chang LJ; Yang LJ; Chan EK
Mol Biol Cell; 2013 Jun; 24(11):1638-48, S1-7. PubMed ID: 23552692
[TBL] [Abstract][Full Text] [Related]
8. CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
Niemelä M; Kauko O; Sihto H; Mpindi JP; Nicorici D; Pernilä P; Kallioniemi OP; Joensuu H; Hautaniemi S; Westermarck J
Oncogene; 2012 Sep; 31(39):4266-78. PubMed ID: 22249265
[TBL] [Abstract][Full Text] [Related]
9. Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway.
Wu J; Ding M; Mao N; Wu Y; Wang C; Yuan J; Miao X; Li J; Shi Z
J Pharmacol Sci; 2017 May; 134(1):22-28. PubMed ID: 28522217
[TBL] [Abstract][Full Text] [Related]
10. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
[TBL] [Abstract][Full Text] [Related]
11. Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer.
Chen W; Liang JL; Zhou K; Zeng QL; Ye JW; Huang MJ
Cell Commun Signal; 2020 Apr; 18(1):67. PubMed ID: 32321509
[TBL] [Abstract][Full Text] [Related]
12. CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
[TBL] [Abstract][Full Text] [Related]
13. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
[TBL] [Abstract][Full Text] [Related]
14. CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.
Zhai M; Cong L; Han Y; Tu G
Tumour Biol; 2014 Feb; 35(2):1123-8. PubMed ID: 24014087
[TBL] [Abstract][Full Text] [Related]
15. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 May; 36(5):3583-9. PubMed ID: 25560487
[TBL] [Abstract][Full Text] [Related]
16. CIP2A regulates proliferation and apoptosis of multiple myeloma cells.
Zheng Z; Qiao Z; Chen W; Gong R; Wang Y; Xu L; Ma Y; Zhang L; Lu Y; Jiang B; Li G; Dong C
Mol Med Rep; 2016 Sep; 14(3):2705-9. PubMed ID: 27484817
[TBL] [Abstract][Full Text] [Related]
17. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
[TBL] [Abstract][Full Text] [Related]
18. CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation.
Puustinen P; Rytter A; Mortensen M; Kohonen P; Moreira JM; Jäättelä M
J Cell Biol; 2014 Mar; 204(5):713-27. PubMed ID: 24590173
[TBL] [Abstract][Full Text] [Related]
19. CIP2A increases self-renewal and is linked to Myc in neural progenitor cells.
Kerosuo L; Fox H; Perälä N; Ahlqvist K; Suomalainen A; Westermarck J; Sariola H; Wartiovaara K
Differentiation; 2010 Jul; 80(1):68-77. PubMed ID: 20447748
[TBL] [Abstract][Full Text] [Related]
20. CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer.
Lei N; Peng B; Zhang JY
Oncol Rep; 2014 Oct; 32(4):1689-94. PubMed ID: 25109354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]